Exco’s eDiary will allow patients to participate in the trial irrespective of their location, age or proximity to the site.
The study, which will focus on new research on electronic monitoring of OAB treatment experience (REMOTE) Phase 4 to treat overactive bladder, will imitate an earlier finished trial to validate this new approach.
With this new approach, the patients will get the chance to participate in the screening process through internet regardless of their location which was earlier not possible.
Further, the patients will be allowed to manage their own trial and report results directly to a trial.
As a result, researchers expect to save time and obtain more reliable, quality data through increased patient compliance and engagement, lower withdrawal rates and real-time data collection.
Pfizer senior director and clinical lead Miguel Orri said the REMOTE virtual trial pilot brings potential to transform how patients access and participate in clinical trials.
"The project brings the potential to accelerate clinical research while improving quality, measures vital to the future of drug development," Orri said.